AI-Generated Validation Protocols: Can They Actually Be GAMP5 and FDA Compliant?

Somewhere in the last 18 months, a quiet shift happened. Quality engineers started feeding legacy IQ/OQ/PQ templates into large language models, adjusting the output, and routing the result through their standard approval workflows. Nobody announced this practice. There was no industry working group. It just spread — because the economics are compelling and the outputs are plausible enough to pass a quick scan.

The problem is that “plausible enough to pass a quick scan” and “defensible under FDA inspection” are not the same standard.

If your team is using AI to draft validation protocols in a GxP environment, you’re operating in a space where neither FDA nor ISPE has published direct rules. But that doesn’t mean the existing frameworks are silent. GAMP 5 Second Edition (2022), FDA’s draft Computer Software Assurance guidance, and 21 CFR Part 11 together give you a workable signal — if you read them closely and resist the temptation to assume silence means permission.

What GAMP 5 Second Edition Actually Says — And Doesn’t Say — About AI

ISPE released GAMP 5 Second Edition in February 2022, roughly three years before AI-assisted documentation became a widespread practice in regulated industries. You won’t find a section titled “Using Generative AI for Validation Protocols.” What you will find is a governing philosophy that has direct and clear implications for how AI-generated content must be treated.

The core of the updated framework is critical thinking over documentation volume. The Second Edition explicitly pushes back against the tick-box validation culture that produced 200-page test script packages for configured commercial-off-the-shelf software that genuinely didn’t require that level of documentation. Instead, GAMP 5 asks validation teams to apply risk-based thinking: what are the critical quality attributes of this system, what could realistically go wrong, and what evidence demonstrates the system performs as intended in your specific environment?

Applied to AI-drafted protocols, this principle cuts in both directions. A risk-based approach accommodates AI as a drafting tool — if the human reviewer applies genuine critical thinking to the output, identifies inaccuracies or gaps, and takes real authorship accountability for every statement in the final document. But the same principle makes it obvious that AI-generated boilerplate, accepted without scrutiny because it looks complete, is precisely the documentation-as-performance behavior GAMP 5 is trying to eliminate.

GAMP 5’s five software categories carry different validation expectations. For Category 4 (configured applications) and Category 5 (custom-developed software), where development documentation and testing rigor are highest, a protocol that reads like a template — structurally sound but generically vague — isn’t just weak. It’s a documentation liability that signals to any experienced auditor that the validation team didn’t understand the system well enough to write specific, defensible acceptance criteria.

FDA’s CSA Guidance and the Author Accountability Problem

FDA’s draft guidance on Computer Software Assurance, published for public comment in September 2022, reinforced what GAMP 5 had been signaling: stop treating documentation as the deliverable and start treating evidence of critical thinking as the actual output of validation.

The CSA framework shifts emphasis from exhaustive record generation to ensuring that testing is meaningful and that the people responsible for a software system actually understand how it functions in their quality environment. That philosophical shift — from paperwork as proof to critical thinking as proof — creates a specific and underappreciated problem for unreviewed AI-generated content.

Under 21 CFR Part 11.10, any electronic record that constitutes part of a GxP compliance file must meet requirements for data integrity, audit trails, and identified authorship. A document cannot be “authored by the AI.” It must be signed off by a qualified person who takes full responsibility for its content. That’s been true since Part 11 was finalized in 1997, and it applies to every record in your validation package, regardless of how the first draft was generated.

This is where teams are getting sloppy in ways that aren’t immediately visible. They use an AI tool to generate 80% of a validation protocol, make surface-level edits for fit, and route it through the standard approval workflow as if it were a document they had written from scratch. The signature is there. The audit trail is there. But if an inspector asks the protocol owner to walk through the acceptance criteria in Section 4 and explain why those specific thresholds were chosen for this system — and the answer reveals the signatory doesn’t actually know — that’s more than a documentation deficiency. It’s evidence of a quality system breakdown.

The practical implication: AI-generated protocol content requires substantive, documented human review — not just a signature at the end. For high-risk or complex systems, that review should be traceable to who reviewed which sections, what was changed, and why.

Where AI-Assisted Protocol Writing Actually Earns Its Keep

None of this means AI has no legitimate place in validation documentation. It has a meaningful place. But the use cases where it adds value without creating regulatory exposure are more specific than the broad promise of “draft my validation package.”

Structural scaffolding is the clearest win. AI tools are genuinely good at generating the skeleton of a validation protocol — numbered sections, standard headers, required tables, IQ/OQ/PQ structural conventions. The framework requirements for these documents are largely consistent across system types, and getting that structure right in a first draft saves 2 to 4 hours of formatting time per document set — time that could go toward substantive testing analysis instead. That’s real efficiency with minimal regulatory risk.

Regulatory language review is a second strong use case. Models trained on regulatory text can flag where draft protocol language deviates from 21 CFR Part 11 or GAMP 5 conventions — “verified” versus “validated,” the correct framing of objective evidence, the distinction between specifications and acceptance criteria. Used as a reviewer rather than an author, AI catches language-level issues that human reviewers miss when they’re focused on technical content.

Risk assessment scaffolding for well-understood Category 3 systems — configured COTS applications with established risk profiles — can reasonably begin as AI-assisted drafts. The generic risk categories (data integrity, access control, backup and recovery, audit trail functionality) are documented well enough that AI can generate a credible starting point. A qualified reviewer then evaluates whether system-specific risks require additional entries and whether the residual risk ratings are actually defensible.

What AI cannot do reliably: write accurate, system-specific acceptance criteria. The moment a protocol requires specific performance thresholds — response time limits, data retention periods, user permission hierarchies — those numbers need to come from engineers who have assessed the actual system. AI will generate plausible-sounding figures. They may or may not reflect reality.

A Risk-Based Framework for AI-Assisted Validation Documentation

If your quality system is going to incorporate AI-drafted content into GxP validation records — and given the economic incentive, many teams already are — the following framework keeps you defensible under current FDA and ISPE expectations.

Step 1: Define your AI use classification. Decide in advance which protocol sections are permissible for AI-drafted content (structural scaffolding, standard regulatory language, boilerplate risk categories) and which require human-authored content (system-specific acceptance criteria, novel risk ratings, site-specific test cases). Document this decision in your validation master plan.

Step 2: Treat AI output as a first draft, not a deliverable. Document it as such. Some regulatory compliance consulting practices are starting to include an “AI-Assisted Drafting” notation in document control metadata — creating an honest paper trail without pretending the AI is the author. That transparency is protective if a gap is ever questioned.

Step 3: Define what substantive review actually means. “Review” in your SOP should require that the reviewer can explain and defend every acceptance criterion, every risk rating, and every test case in the document. If the reviewer can’t do that, the review didn’t happen. For critical systems, consider a dual-reviewer model: one reviewer for technical accuracy, a second for regulatory language.

Step 4: Qualify your AI tool if it touches regulated records. This is where teams consistently underestimate the scope of their obligations. If an AI tool generates or edits content that becomes part of a GxP record — particularly if it’s integrated into your document management system — that tool may itself require validation or qualification under GAMP 5. Category 4 requirements may apply depending on how the system is configured and what it produces.

Step 5: Update your Validation Master Plan. If AI-assisted drafting is an established practice in your organization, your VMP should describe it. An inspector who discovers AI-related content in your protocol packages without any reference to AI tools in your VMP has a visible gap to pursue. Closing that gap proactively is straightforward; explaining it reactively during an inspection is not.

The Honest Assessment

AI tools are going to change how validation documentation gets written — that’s already underway, and no amount of regulatory caution will reverse the trajectory. The question isn’t whether to use them. It’s whether your quality system is mature enough to use them without manufacturing the kind of generic, analytically thin documentation that FDA’s CSA guidance was specifically written to discourage.

The companies that will fare best in inspections over the next 3 to 5 years are those that use AI to accelerate the mechanical parts of documentation while investing the time saved in deeper, more defensible critical thinking. That’s the spirit of both GAMP 5 Second Edition and CSA — and it also happens to describe the most productive use of these tools in a GxP context.

If your team is currently using AI for validation protocols without a documented framework governing that use, that gap is worth closing now — before an inspector identifies it for you.

Written by Sam Sammane, Founder & CEO, Aurora TIC | Founder, Qalitex Group. Learn more about our team

Reserve early access to our AI audit tools — including ChatGMP and DeepGMP, purpose-built for GxP validation workflows. Contact us

Related from our network

• ISO 17025-Accredited Lab Testing for Software-Adjacent Quality Systems — Qalitex Laboratories provides analytical testing and compliance documentation support for regulated manufacturers across the US.
• GxP-Compliant Laboratory Qualification and Validation Support in Canada — Androxa supports Canadian pharmaceutical and NHP manufacturers with lab qualification, method validation, and Health Canada compliance documentation.